Antigenic mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice

Vaccine

Volumn 29, Issue 50, 2011, Pages 9321-9328

  Ishibashi, Daisuke ^a   Yamanaka, Hitoki ^a   Mori, Tsuyoshi ^b   Yamaguchi, Naohiro ^a   Yamaguchi, Yoshitaka ^b   Nishida, Noriyuki ^a   Sakaguchi, Suehiro ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antigenic mimicry; Humoral immunity; Prion; Vaccine

Indexed keywords

BACTERIAL ENZYME; EPITOPE; PRION PROTEIN; PRION PROTEIN ANTIBODY; RECOMBINANT SUCCINYLARGININE DIHYDROLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INFECTION PREVENTION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION; PRION DISEASE; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; BACTERIAL PROTEINS; EPITOPES; FEMALE; HYDROLASES; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; PRION DISEASES; PRIONS; RECOMBINANT PROTEINS;

EID: 80855131605     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.017     Document Type: Article

References (23)

1. Prusiner S.B. Prions. Proc Natl Acad Sci USA 1998, 95(23):13363-13383.
2. Weissmann C., Enari M., Klohn P.C., Rossi D., Flechsig E. Molecular biology of prions. Acta Neurobiol Exp (Warsz) 2002, 62(3):153-166.
3. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., et al. The same prion strain causes vCJD and BSE. Nature 1997, 389(6650):448-450.
4. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389(6650):498-501.
5. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004, 363(9407):417-421.
6. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004, 364(9433):527-529.
7. Zou S., Fang C.T., Schonberger L.B. Transfusion transmission of human prion diseases. Transfus Med Rev 2008, 22(1):58-69.
8. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 2001, 294(5540):178-182.
9. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003, 422(6927):80-83.
10. Wang F., Wang X., Yuan C.G., Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010, 327(5969):1132-1135.
11. Ishibashi D., Yamanaka H., Yamaguchi N., Yoshikawa D., Nakamura R., Okimura N., et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine 2007, 25(6):985-992.
12. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., et al. Prions prevent neuronal cell-line death. Nature 1999, 400(6741):225-226.
13. Nishida N., Katamine S., Manuelidis L. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures. Science 2005, 310(5747):493-496.
14. Tateishi J., Ohta M., Koga M., Sato Y., Kuroiwa Y. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 1979, 5(6):581-584.
15. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997, 390(6655):74-77.
16. Cunin R., Glansdorff N., Pierard A., Stalon V. Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev 1986, 50(3):314-352.
17. Sigurdsson E.M., Brown D.R., Daniels M., Kascsak R.J., Kascsak R., Carp R., et al. Immunization delays the onset of prion disease in mice. Am J Pathol 2002, 161(1):13-17.
18. Polymenidou M., Heppner F.L., Pellicioli E.C., Urich E., Miele G., Braun N., et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci USA 2004, 101(Suppl. 2):14670-14676.
19. Yamanaka H., Ishibashi D., Yamaguchi N., Yoshikawa D., Nakamura R., Okimura N., et al. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin. Vaccine 2006, 24(15):2815-2823.
20. Koller M.F., Grau T., Christen P. Induction of antibodies against murine full-length prion protein in wild-type mice. J Neuroimmunol 2002, 132(1-2):113-116.
21. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004, 303(5663):1514-1516.
22. Lefebvre-Roque M., Kremmer E., Gilch S., Zou W.Q., Feraudet C., Gilles C.M., et al. Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion 2007, 1(3):198-206.
23. Goni F., Prelli F., Schreiber F., Scholtzova H., Chung E., Kascsak R., et al. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 2008, 153(3):679-686.